Literature DB >> 22014662

The constitutively active Ah receptor (CA-AhR) mouse as a model for dioxin exposure - effects in reproductive organs.

Sara Brunnberg1, Patrik Andersson, Lorenz Poellinger, Annika Hanberg.   

Abstract

The dioxin/aryl hydrocarbon receptor (AhR) mediates most toxic effects of dioxins. In utero/lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) impairs fetal/neonatal development and the developing male reproductive tract are among the most sensitive tissues. TCDD causes antiestrogenic responses in rodent mammary gland and uterus and in human breast cancer cell lines in the presence of estrogen. Also, more recently an estrogen-like effect of TCDD/AhR has been suggested in the absence of estrogen. A transgenic mouse expressing a constitutively active AhR (CA-AhR) was developed as a model mimicking a situation of constant exposure to AhR agonists. Male and female reproductive tissues of CA-AhR mice were characterized for some of the effects commonly seen after dioxin exposure. Sexually mature CA-AhR female mice showed decreased uterus weight, while an uterotrophic assay in immature CA-AhR mice resulted in increased uterus weight. In immature mice, both TCDD-exposure and CA-AhR increased the expression of the estrogen receptor target gene Cathepsin D. When co-treated with 17β-estradiol no increase in Cathepsin D levels occurred in either TCDD-exposed or CA-AhR mice. In sexually mature male CA-AhR mice the weights of testis and ventral prostate were decreased and the epididymal sperm reserve was reduced. The results of the present study are in accordance with previous studies on dioxin-exposed rodents in that an activated AhR (here CA-AhR) leads to antiestrogenic effects in the presence of estrogen, but to estrogenic effects in the absence of estrogen. These results suggest the CA-AhR mouse model as a useful tool for studies of continuous low activity of the AhR from early development, resembling the human exposure situation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014662     DOI: 10.1016/j.chemosphere.2011.09.015

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  9 in total

Review 1.  Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations.

Authors:  Susan L Teitelbaum; Fiorella Belpoggi; Les Reinlib
Journal:  Reprod Toxicol       Date:  2014-12-27       Impact factor: 3.143

Review 2.  The association of peripubertal serum concentrations of organochlorine chemicals and blood lead with growth and pubertal development in a longitudinal cohort of boys: a review of published results from the Russian Children's Study.

Authors:  Oleg Sergeyev; Jane S Burns; Paige L Williams; Susan A Korrick; Mary M Lee; Boris Revich; Russ Hauser
Journal:  Rev Environ Health       Date:  2017-03-01       Impact factor: 3.458

3.  Cardiac myocyte-specific AHR activation phenocopies TCDD-induced toxicity in zebrafish.

Authors:  Kevin A Lanham; Jessica Plavicki; Richard E Peterson; Warren Heideman
Journal:  Toxicol Sci       Date:  2014-07-18       Impact factor: 4.849

4.  Effects of Adipocyte Aryl Hydrocarbon Receptor Deficiency on PCB-Induced Disruption of Glucose Homeostasis in Lean and Obese Mice.

Authors:  Nicki A Baker; Robin Shoemaker; Victoria English; Nika Larian; Manjula Sunkara; Andrew J Morris; Mary Walker; Frederique Yiannikouris; Lisa A Cassis
Journal:  Environ Health Perspect       Date:  2015-03-03       Impact factor: 9.031

Review 5.  Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.

Authors:  Louisane Eve; Béatrice Fervers; Muriel Le Romancer; Nelly Etienne-Selloum
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 6.  Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.

Authors:  Chandra K Maharjan; Jiao Mo; Lei Wang; Myung-Chul Kim; Sameul Wang; Nicholas Borcherding; Praveen Vikas; Weizhou Zhang
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

7.  Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer.

Authors:  Leon J S Brokken; Yvonne Lundberg-Giwercman; Ewa Rajpert-De Meyts; Jakob Eberhard; Olof Ståhl; Gabriella Cohn-Cedermark; Gedske Daugaard; Stefan Arver; Aleksander Giwercman
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-14       Impact factor: 5.555

8.  The AhR Ligand, TCDD, Regulates Androgen Receptor Activity Differently in Androgen-Sensitive versus Castration-Resistant Human Prostate Cancer Cells.

Authors:  Maryam Ghotbaddini; Joann B Powell
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390

9.  Chronic aryl hydrocarbon receptor activity phenocopies smoking-induced skeletal muscle impairment.

Authors:  Trace Thome; Kayla Miguez; Alexander J Willms; Sarah K Burke; Vijayendran Chandran; Angela R de Souza; Liam F Fitzgerald; Carolyn Baglole; Maria-Eleni Anagnostou; Jean Bourbeau; R Thomas Jagoe; Jose A Morais; Yana Goddard; Tanja Taivassalo; Terence E Ryan; Russell T Hepple
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-11-01       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.